These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37700807)

  • 1. Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer.
    Fang ZX; Hou YY; Wu Z; Wu BX; Deng Y; Wu HT; Liu J
    World J Clin Oncol; 2023 Aug; 14(8):297-310. PubMed ID: 37700807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer.
    Fang ZX; Li CL; Chen WJ; Wu HT; Liu J
    World J Gastrointest Oncol; 2022 Sep; 14(9):1675-1688. PubMed ID: 36187390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
    Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
    Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
    [No Abstract]   [Full Text] [Related]  

  • 4. Six-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma.
    Ju MH; Jang EJ; Kang SH; Roh YH; Jeong JS; Han SH
    J Hepatocell Carcinoma; 2023; 10():643-658. PubMed ID: 37101765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 6. Progesterone receptor gene serves as a prognostic biomarker associated with immune infiltration in gastric cancer: a bioinformatics analysis.
    Li M; Zhou C
    Transl Cancer Res; 2021 Jun; 10(6):2663-2677. PubMed ID: 35116579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer.
    Bao D; Zhang C; Li L; Wang H; Li Q; Ni L; Lin Y; Huang R; Yang Z; Zhang Y; Hu Y
    Front Oncol; 2020; 10():553297. PubMed ID: 33614473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GHRL as a prognostic biomarker correlated with immune infiltrates and progression of precancerous lesions in gastric cancer.
    Wang J; Liu D; Xie Y
    Front Oncol; 2023; 13():1142017. PubMed ID: 37469414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer.
    Zheng P; Liu X; Li H; Gao L; Yu Y; Wang N; Chen H
    Front Genet; 2021; 12():796592. PubMed ID: 35126464
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer.
    Jian F; Yanhong J; Limeng W; Guoping N; Yiqing T; Hao L; Zhaoji P
    Int Immunopharmacol; 2022 Sep; 110():109008. PubMed ID: 35792273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CALD1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers.
    Liu Y; Xie S; Zhu K; Guan X; Guo L; Lu R
    Heliyon; 2021 Jun; 7(6):e07257. PubMed ID: 34189308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pan-Cancer Crosstalk Between the
    Xie R; Yuan M; Jiang Y
    Front Cell Dev Biol; 2022; 10():790947. PubMed ID: 35309935
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
    Liu D; Liu S; Fang Y; Liu L; Hu K
    Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
    Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
    J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of CXCR4 as a Prognostic Biomarker Associated With the Tumor Immune Microenvironment in Gastric Cancer.
    Gu Y; Gu W; Xie R; Chen Z; Xu T; Fei Z
    Front Cell Dev Biol; 2021; 9():654504. PubMed ID: 34568309
    [No Abstract]   [Full Text] [Related]  

  • 19. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
    Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
    Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
    [No Abstract]   [Full Text] [Related]  

  • 20. Comprehensive analysis of the prognostic value and immune infiltration of
    Yang C; Song D; Zhao F; Wu J; Zhang B; Ren H; Sun Q; Qin S
    Front Oncol; 2022; 12():936952. PubMed ID: 36147913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.